MARC2 anticorps (C-Term)

N° du produit ABIN652632

Détail du produit anti-MARC2 anticorps

Antigène: MARC2 (Mitochondrial Amidoxime Reducing Component 2 (MARC2))

Épitope: AA 270-300, C-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MARC2 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This MOSC2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 270-300 amino acids from the C-terminal region of human MOSC2.

Clone: RB22590

Isotype: Ig Fraction

Information d'application

Indications d'application: WB: 1:1000. WB: 1:1000. IHC-P: 1:50~100. FC: 1:10~50

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.

Date de péremption: 6 months

Détails sur MARC2

Antigène: MARC2 (Mitochondrial Amidoxime Reducing Component 2 (MARC2))

Autre désignation: MOSC2 (MARC2 Produits)

Synonymes: anticorps MOSC2, anticorps RP11-270A6.1, anticorps 2810484M10Rik, anticorps Mosc2, anticorps mARC1, anticorps Mg87, anticorps mARC2, anticorps mitochondrial amidoxime reducing component 1, anticorps mitochondrial amidoxime reducing component 2, anticorps MARC1, anticorps MARC2, anticorps Marc2

Sujet: Catalytic component of the benzamidoxime prodrug-converting complex, a complex required to reduce N-hydroxylated structures, such as benzamidoxime prodrug. Benzamidoxime is an amidine prodrug produced by N-hydroxylation which is used to enhance bioavailability and increase intestinal absorption. It is then reduced into benzamidine, its active amidine, by the benzamidoxime prodrug-converting complex.

Poids moléculaire: 38023

ID gène: 54996

NCBI Accession: NP_060368

UniProt: Q969Z3